- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 88
Buoy Health marks off series C funding
The healthcare navigation software provider closed a $37.5m round co-led by Cigna Ventures and Humana and backed by Optum Ventures.
Nov 13, 2020Eko tunes into $65m series C
3M Ventures and NTTVC joined new and existing investors to help the cardiopulmonary virtual care provider boost its overall funding to $92m.
Nov 11, 2020Keya collects series C cash
Tasly took part in a $30.2m round for medical imaging services provider Keya Medical Technology, which has now raised cash three times this year.
Nov 11, 2020Nuro lures Vision Fund to $500m series C
Delivery vehicle provider Nuro has almost doubled its valuation to $5bn in a series C round featuring returning investor SoftBank Vision Fund.
Nov 10, 2020SoftBank reaches new Tier in $250m round
The scooter sharing platform developer has pulled in series C funding through a round led by SoftBank Vision Fund 2 that will support its entry into new markets.
Nov 10, 2020Pony.ai makes leap to $267m series C
Newly minted strategic partner FAW Group was among the participants as the autonomous driving system developer pushed its valuation to $5.3bn.
Nov 9, 2020Congenica conjures up $50m
CIC and Parkwalk have returned to back patient-focused genomic analysis developer Congenica, bringing its funding total to $85m.
Nov 9, 2020Apollomics applies itself to $124m series C
Crown Bioscience spinoff Apollomics has closed a round led by Ping An Capital that will support clinical testing of its immuno-oncology drug pipeline.
Nov 9, 2020Congenica conjures up $50m
Tencent and Legal & General co-led a series C round for genomic testing software provider Congenica that will fund the expansion of its partnership activities.
Nov 9, 2020Sofie Biosciences gets Jubilant series C investment
Diagnostics technology provider Sofie has completed a $27.4m series C round led by $25m from Jubilant Radiopharma at a $100m valuation.
Nov 9, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


